Volume 8 Issue 1 - International Pharmaceutical Industry

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Editorial Archive

Temperature-controlled Packaging: More Than Just an Insulated Box

The demand to frequently transport temperature-sensitive products with greater compliance and often in more difficult conditions is increasing. This places temperatu...

19 July 2016 Editorial Archive | Labs & Logistics V8 I1 | Volume 8 Issue 1

Continue Reading →

Clinical Research V8 I1

Genomics and Precision Medicine: Marketing Challenges and Opportunities

In an age of big data, companies now have more power to respond to their customers as individuals. Ever since the first internet shops discovered that tracking users...

19 July 2016 Clinical Research V8 I1 | Editorial Archive | Volume 8 Issue 1

Continue Reading →

Clinical Research V8 I1

Systemic Epigenetic Biomarkers for ALS Improve Early Diagnosis, Treatment, and Trials

Amyotrophic lateral sclerosis (ALS) or Lou Gehrig's disease is a devastating, rapidly progressive and invariably fatal neurological disease that attacks the nerve ce...

19 July 2016 Clinical Research V8 I1 | Editorial Archive | Volume 8 Issue 1

Continue Reading →

Drug Discovery, Development & Delivery V8 I1

Engineering of Enzymes for Industrial Biocatalysis

Enzymes are important biocatalysts with many applications in medicine, food technology and the chemical industry. To further expand their reaction scope and to meet ...

19 July 2016 Drug Discovery, Development & Delivery V8 I1 | Editorial Archive | Volume 8 Issue 1

Continue Reading →

Drug Discovery, Development & Delivery V8 I1

Where are the Gaps in your Data?

In drug discovery, data is king. Gathering the right information makes it easier to design better compounds, faster. How can you be sure that you are getting the mos...

19 July 2016 Drug Discovery, Development & Delivery V8 I1 | Editorial Archive | Volume 8 Issue 1

Continue Reading →

Drug Discovery, Development & Delivery V8 I1

Contribution of Circulating Tumour Cells in Drug Development

Circulating tumour cells (CTCs) are becoming very welcome in the field of oncology, and they are also promising in the clinical field, in the area of drug developmen...

19 July 2016 Drug Discovery, Development & Delivery V8 I1 | Drug Discovery, Development and Delivery V8 I1 | Editorial Archive | Volume 8 Issue 1

Continue Reading →

Drug Discovery, Development & Delivery V8 I1

Applications of CRISPR

Scientific interest in Clustered Regularly Interspaced Palindromic Repeats (CRISPR) systems exploded in 2012/2013 when focus shifted from their natural function as a...

19 July 2016 Drug Discovery, Development & Delivery V8 I1 | Drug Discovery, Development and Delivery V8 I1 | Editorial Archive | Volume 8 Issue 1

Continue Reading →

Editorial Archive

How to Protect Your IP Rights Abroad

Many life sciences companies which protect their inventions, brands or product designs through patents, trademarks or registered designs in their home country, do no...

19 July 2016 Editorial Archive | Regulatory & Marketplace V8 I1 | Volume 8 Issue 1

Continue Reading →

Editorial Archive

Why Agility Holds the Key to Transformation in Life Sciences

The priority that will unite all life sciences companies in 2016 is the pursuit of greater agility. As long as organisations keep taking a short-term view, investing...

19 July 2016 Editorial Archive | Regulatory & Marketplace V8 I1 | Volume 8 Issue 1

Continue Reading →

Editorial Archive

The Total IDMP Effort – an insight into the data volume of an ISO IDMP submission

It has, since 2012, been a well-established fact that pharmaceutical companies which have medicinal products or are conducting clinical trials in the European Union ...

19 July 2016 Editorial Archive | Regulatory & Marketplace V8 I1 | Volume 8 Issue 1

Continue Reading →